PHARMACEUTICALS
35 articole · RSS
Remedia Deva Bets On Cosmetics And Partnerships For Profit
The management of pharmaceuticals wholesaler Farmaceutica Remedia Deva (RMAH.RO) controlled by businessman Valentin Norbert Tarus, expects pressure on profitability margins to continue in th...
Antitrust Authorities To Soon Finish Investigations Targeting Food And Electronics Retailers, Drug Distributors
Bogdan Chiritoiu, president of the Competition Council, announced that the institution will next year conclude an investigation into agreements between retailers such as Metro, Billa and Sel...
Advent To Make Discreet Exit From Labormed
International private equity firm Advent International is preparing a discreet exit from Labormed in a complex process, which will in a first stage involve handing over its stake to individu...
Terapia Ranbaxy Beats Rival Europharm To The Top Spot In 2011
Terapia Ranbaxy in Cluj became Romania’s largest drug maker last year, leaving rival Europharm behind by just EUR3 million. Terapia came close to EUR100 million in revenue and had the highes...
Top 15 Romanian Drug Producers Posted EUR315M Revenue In 2011
The 15 largest local drug producers posted EUR315 million in revenue together last year, which accounts for 12% of a market dominated by importers. This means the 15 Romanian pharmaceutical...
Roche Heads Towards First Billion Lei Driven By 5% Growth
Roche Romania estimates to have ended 2011 with approximately 900 million lei (EUR207 million) in sales, while the 2012 budget is conservative, built in lei around expectations of growth.
Romastru Targets EUR85m Turnover
Romastru Trading, a company active in pharmaceutical marketing and wholesale, has budgeted a turnover of EUR85 million for this year. EUR4 million to EUR5 million should be generated by the...
Pharmaceutical Market Growth Continues Slowdown. Sales Up 5.5% On Year In First 4 Months
The pharmaceutical market reached EUR836.9 million in the first four months of this year, up 5.5% from a year ago, according to the data provided by research firm IMS Health.